Institutional Investors in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) See US$446m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
BTIG Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
BTIG Sticks to Their Hold Rating for PROCEPT BioRobotics (PRCT)
Wells Fargo Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $112
Procept BioRobotics Resumed With an Overweight at Wells Fargo
Procept Biorobotics Insider Sold Shares Worth $2,584,638, According to a Recent SEC Filing
Yolo_tdm : thank u
Stock_Drift OP Yolo_tdm : YW. Appreciate it.
105711459 : Appreciate it, crazy performance by $Healthcare Triangle (HCTI.US)$
Boxman Stock_Drift OP : Nice volume here
Stock_Drift OP Boxman : Unusually nice.
View more comments...